Showing results (11-20 of 83) with videos related to
Sort By:
Pageof 9
Nature Reviews. Drug Discovery|March 1, 2008
Hormones of the gut-brain axis as targets for the treatment of upper gastrointestinal disordersGareth J Sanger, Kevin LeeNeuroscience Letters|February 8, 2005
Effect of a selective and potent central nervous system penetrant, neurokinin-3 receptor antagonist (SB-222200), on cisplatin-induced emesis in the ferretAndrew G King, Gareth J SangerCurrent Opinion in Pharmacology|December 17, 2002
Intrinsic nerve circuits of the gastrointestinal tract: identification of drug targetsJohn B Furness, Gareth J SangerCurrent Treatment Options in Oncology|November 27, 2020
The Benefits of Olanzapine in Palliating SymptomsMellar P Davis, Gareth J SangerNature Reviews. Gastroenterology & Hepatology|September 23, 2015
Ghrelin and motilin receptors as drug targets for gastrointestinal disordersGareth J Sanger, John B FurnessCurrent Opinion in Pharmacology|December 17, 2002
Drugs targeting functional bowel disorders: insights from animal studiesGareth J Sanger, Gareth A HicksExpert Opinion on Investigational Drugs|January 28, 2017
Investigational drug therapies for the treatment of gastroparesisGareth J Sanger, Pankaj Jay PasrichaGlia|September 21, 2022
Effect of old age on the subpopulations of enteric glial cells in human descending colonNicholas Baidoo, Gareth J Sanger, Abi BelaiCurrent Opinion in Pharmacology|December 17, 2002
Abdominal vagal afferent neurones: an important target for the treatment of gastrointestinal dysfunctionPaul L R Andrews, Gareth J SangerFrontiers in Pharmacology|September 21, 2018
A History of Drug Discovery for Treatment of Nausea and Vomiting and the Implications for Future ResearchGareth J Sanger, Paul L R AndrewsPageof 9